XCHO.OB: Summary for XENACARE HOLDINGS - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 1:26am EST - Canadian Markets open in 8 hours and 4 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Xenacare Holdings Inc. (XCHO.OB)

On Feb 9: 0.275 USD

0.035 (14.58%)

MORE ON XCHO.OB

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

XENACARE HOLDINGS (OTC BB:XCHO.OB) Delayed quote data

Last Trade:	0.275 USD
Trade Time:	Feb 9
Change:	0.035 (14.58%)
Prev Close:	0.24
Open:	0.247
Bid:	0.222 x 5000
Ask:	0.29 x 5000
1y Target Est:	N/A

Day's Range:	0.23 - 0.285
52wk Range:	0.01 - 0.32
Volume:	457,791
Avg Vol (3m):	281,421
Market Cap:	18.08M
P/E (ttm):	N/A
EPS (ttm):	-0.043
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y

Add XCHO.OB to Portfolio

Download Data

HEADLINES

•	Nutra Pharma Announces Fourth Quarter Sales for Its Over-the-Counter (OTC) Pain Reliever, Cobroxin
	Business Wire (Tue, Feb 2)

•	XenaCare Holdings Announces Expansion of National Advertising Campaign for its Over-the-Counter (OTC) Pain Reliever, Cobroxin, as Retailer Commitments
	Business Wire (Tue, Jan 19)

•	XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation
	Business Wire (Fri, Nov 27)

•	XENACARE HOLDINGS, INC. Financials
	EDGAR Online Financials (Sat, Nov 21)

•	XENACARE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Mon, Nov 16)

•	XENACARE HOLDINGS, INC. Files SEC form 10-Q/A, Quarterly Report
	EDGAR Online (Fri, Oct 2)

•	XENACARE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Wed, Aug 19)

•	XENACARE HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Tue, May 19)

•	XENACARE HOLDINGS, INC. Financials
	EDGAR Online Financials (Tue, Apr 28)

•	XENACARE HOLDINGS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Fri, Mar 13)

More Headlines for XCHO.OB...

BUSINESS SUMMARY

XenaCare Holdings, Inc. engages in the formulation, marketing, and distribution of nutrition supplement products primarily in the United States. Its clinical products include XenaCor, which lowers serum cholesterol, C-reactive protein, and homocys...

Full Company Profile

Add to Portfolio

Email to a Friend

•